Canaccord Genuity Upgrades Cardiome Pharma (CRME) to Buy
Tweet
Share
E-mailGet Alerts CRME Hot Sheet
Price: $2.33 --0%
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Canaccord Genuity upgraded Cardiome Pharma (NASDAQ: CRME) from Hold to Buy with a price target increased from $6.50 of $8.00.
For more ratings news on Cardiome Pharma click here and for the rating history of Cardiome Pharma click here.
Shares of Cardiome Pharma closed at $4.34 yesterday.
For more ratings news on Cardiome Pharma click here and for the rating history of Cardiome Pharma click here.
Shares of Cardiome Pharma closed at $4.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Hyliion Holdings (HYLN) to Outperform 'on Improved Visibility to KARNO Commercialization'
- Johnson Rice Upgrades Core Laboratories (CLB) to Buy
- Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
